5 studies found for:    pediatric neurofibromatosis brain tumor
Show Display Options
Rank Status Study
1 Active, not recruiting NF1 Brain Tumor Genetic Risk
Conditions: Neurofibromatosis Type 1;   Pediatric Brain Tumor
2 Recruiting Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Conditions: Glioma;   Neurofibromatosis Type 1;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Visual Pathway Glioma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Selumetinib
3 Not yet recruiting Phase I/II Study of MEK162 for Children With Ras/Raf Pathway Activated Tumors
Conditions: Low-Grade Gliomas;   Malignant Neoplasms, Brain;   Soft Tissue Neoplasms
Intervention: Drug: MEK162
4 Enrolling by invitation Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
Conditions: Ewing Sarcoma;   Osteosarcoma;   Neuroblastoma;   Acute Lymphoblastic Leukemia;   Neurofibromatosis Type 1
5 Unknown  Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Conditions: Neurofibromatosis 2;   Vestibular Schwannoma
Intervention: Drug: Lapatinib

Indicates status has not been verified in more than two years